A study by The Baker Institute for Public Policy highlights the critical role of immigrant healthcare professionals in the U.S. health system, examining their increasing presence and the impact of legal pathways like the J-1 Visa Exchange Visitor Program.
Bright Minds Biosciences Announces Positive Topline Data for its First-in-Human Phase 1 Study of Lead Compound, BMB-101 | Psychedelic Invest
Bright Minds Biosciences Inc. (CSE:DRUG / NASDAQ:DRUG), a biotechnology company focused on developing novel drugs for the targeted treatment of neuropsychiatric disorders and refractory epilepsy,